Patent details

EP2168599 Title: CANCER REMEDY CONTAINING ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-17 OF PERIOSTIN

Basic Information

Publication number:
EP2168599
PCT Application Number:
PCT/JP/2008/061768
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087776803
PCT Publication Number:
WO/2009/001940
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
CANCER REMEDY CONTAINING ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-17 OF PERIOSTIN
French Title of Invention:
REMÈDE ANTICANCÉREUX CONTENANT UN ANTICORPS DIRIGÉ CONTRE UN PEPTIDE CODÉ PAR L'EXON-17 DE LA PÉRIOSTINE
German Title of Invention:
KREBSHEILMITTEL MIT EINEM ANTIKÖRPER GEGEN EIN VOM EXON-17-BEREICH VON PERIOSTIN KODIERTES PEPTID
SPC Number:

Dates

Filing date:
27/06/2008
Grant date:
10/08/2016
EP Publication Date:
10/08/2016
PCT Publication Date:
31/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/03/2010
EP B1 Publication Date:
10/08/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/06/2017
Expiration date:
27/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/06/2008
 
 

Name:
Osaka University
Address:
1-1, Yamadaoka, Suita-shi Osaka 565-0871, Japan (JP)

Inventor

1

Name:
MORISHITA Ryuichi
Address:
Japan (JP)

2

Name:
TANIYAMA Yoshiaki
Address:
Japan (JP)

3

Name:
KATSURAGI Naruto
Address:
Japan (JP)

Priority

1

Priority Number:
2007169494
Priority Date:
27/06/2007
Priority Country:
Japan (JP)

2

Priority Number:
2008033827
Priority Date:
14/02/2008
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages